Author

A. Korosec

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 2 Approach:experimental assay· 2 Approach:statistical model· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:drug response / drug discovery· 1 Research Focus:gene regulatory network inference· 1

Frequent Co-Authors

A. Alimohammadi· 1 shared A. Farhat· 1 shared A. Forsthuber· 1 shared A. Hladik· 1 shared A. Soler Cardona· 1 shared A.-D. Gorki· 1 shared B. Aschenbrenner· 1 shared B. Gesslbauer· 1 shared

Activity by Year

2022-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Alimohammadi

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer associated fibroblast subtypes modulate the tumor-immune microenvironment and are associated with skin cancer malignancy

A. Forsthuber, B. Aschenbrenner, A. Korosec, T. Jacob, K. Annusver, N. Krajic, D. Kholodniuk, S. Frech, S. Zhu, K. Purkhauser, K. Lipp, F. Werner, V. Nguyen, J. Griss, W. Bauer, , B. M. Lichtenberger

This study identifies three CAF subtypes in skin cancers and shows their association with tumor malignancy and immune modulation.

bioRxiv · May 3, 2023Cancer Biology

A neutrophil-B-cell axis governs disease tolerance during sepsis via Cxcr4

R. Gawish, B. Maier, G. Obermayer, M. Watzenboeck, A.-D. Gorki, F. Quattrone, A. Farhat, K. Lakovits, A. Hladik, A. Korosec, A. Alimohammadi, I. Mesteri, F. Oberndorfer, F. Oakley, J. Brain, , S. Knapp

This study identifies a neutrophil-B-cell axis that promotes disease tolerance during sepsis through Cxcr4 activation, reducing organ damage and immunothrombosis.

bioRxiv · Mar 21, 2022Immunology